The CAPN10 gene is associated with insulin resistance phenotypes in the spanish population

PLoS ONE

Volumn 3, Issue 8, 2008, Pages

  Sáez, María E ^a   González Sánchez, José L ^b   Ramírez Lorca, Reposo ^a   Martínez Larrad, María T ^b   Zabena, Carina ^b   González, Alejandro ^c   Morón, Francisco J ^a   Ruiz, Agustín ^a   Serrano Ríos, Manuel ^b  

^a Neocodex   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c Centro Avanzado de Fertilidad CAF   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CALPAIN 10; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; CALPAIN; DNA; LIPID;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; EPIDEMIOLOGICAL DATA; FAMILY STUDY; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HAPLOTYPE; HEALTH CARE ORGANIZATION; HEREDITY; HUMAN; INDUSTRIALIZATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PHYSICAL ACTIVITY; POPULATION GENETICS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; AGED; BLOOD; CAUCASIAN; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED;

ADULT; AGED; BLOOD GLUCOSE; CALPAIN; DNA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INSULIN RESISTANCE; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHENOTYPE; POLYCYSTIC OVARY SYNDROME; SPAIN;

EID: 51449104508     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002953     Document Type: Article

References (46)

1. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, et al. (2000) Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26: 163-175.
2. Cox NJ, Hayes MG, Roe CA, Tsuchiya T, Bell GI (2004) Linkage of calpain 10 to type 2 diabetes: the biological rationale. Diabetes 53 Suppl 1: S19-25.
3. Fullerton SM, Bartoszewicz A, Ybazeta G, Horikawa Y, Bell GI, et al. (2002) Geographic and haplotype structure of candidate type 2 diabetes susceptibility variants at the calpain-10 locus. Am J Hum Genet 70: 1096-1106.
4. Song Y, Niu T, Manson JE, Kwiatkowski DJ, Liu S (2004) Are variants in the CAPN10 gene related to risk of type 2 diabetes? A quantitative assessment of population and family-based association studies. Am J Hum Genet 74: 208-222.
5. Tsuchiya T, Schwarz PE, Bosque-Plata LD, Geoffrey Hayes M, Dina C, et al. (2006) Association of the calpain-10 gene with type 2 diabetes in Europeans: results of pooled and meta-analyses. Mol Genet Metab 89: 174-184.
6. Elbein SC, Chu W, Ren Q, Hemphill C, Schay J, et al. (2002) Role of calpain-10 gene variants in familial type 2 diabetes in Caucasians. J Clin Endocrinol Metab 87: 650-654.
7. Fingerlin TE, Erdos MR, Watanabe RM, Wiles KR, Stringham HM, et al. (2002) Variation in three single nucleotide polymorphisms in the calpain-10 gene not associated with type 2 diabetes in a large Finnish cohort. Diabetes 51: 1644-1648.
8. Lynn S, Evans JC, White C, Frayling TM, Hattersley AT, et al. (2002) Variation in the calpain-10 gene affects blood glucose levels in the British population. Diabetes 51: 247-250.
9. Orho-Melander M, Klannemark M, Svensson MK, Ridderstrale M, Lindgren CM, et al. (2002) Variants in the calpain-10 gene predispose to insulin resistance and elevated free fatty acid levels. Diabetes 51: 2658-2664.
10. Baier LJ, Permana PA, Yang X, Pratley RE, Hanson RL, et al. (2000) A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest 106: R69-73.
11. Stumvoll M, Fritsche A, Madaus A, Stefan N, Weisser M, et al. (2001) Functional significance of the UCSNP-43 polymorphism in the CAPN10 gene for proinsulin processing and insulin secretion in nondiabetic Germans. Diabetes 50: 2161-2163.
12. Diaz-Villasenor A, Hiriart M, Cebrian ME, Zacarias-Castillo R, Ostrosky-Wegman P (2007) The activity of calpains in lymphocytes is glucose-dependent and is decreased in diabetic patients. Blood Cells Mol Dis. Oct. 25 [Epub ahead of print].
13. Norton L, Parr T, Chokkalingam K, Bardsley RG, Ye H, et al. (2008) Calpain-10 Gene and Protein Expression in Human Skeletal Muscle: Effect of Acute Lipid-Induced Insulin Resistance and Type 2 Diabetes. J Clin Endocrinol Metab 93: 992-998.
14. Tschritter O, Fritsche A, Shirkavand F, Machicao F, Haring H, et al. (2003) Assessing the shape of the glucose curve during an oral glucose tolerance test. Diabetes Care 26: 1026-1033.
15. Ehrmann DA, Schwarz PE, Hara M, Tang X, Horikawa Y, et al. (2002) Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome. J Clin Endocrinol Metab 87: 1669-1673.
16. Gonzalez A, Abril E, Roca A, Aragon MJ, Figueroa MJ, et al. (2002) Comment: CAPN10 alleles are associated with polycystic ovary syndrome. J Clin Endocrinol Metab 87: 3971-3976.
17. Gonzalez A, Abril E, Roca A, Aragon MJ, Figueroa MJ, et al. (2003) Specific CAPN10 gene haplotypes influence the clinical profile of polycystic ovary patients. J Clin Endocrinol Metab 88: 5529-5536.
18. Vollmert C, Hahn S, Lamina C, Huth C, Kolz M, et al. (2007) Calpain-10 variants and haplotypes are associated with polycystic ovary syndrome in Caucasians. Am J Physiol Endocrinol Metab 292: E836-844.
19. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106: 3143-3421.
20. Ferrannini E, Haffner SM, Mitchell BD, Stem MP (1991) Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34: 416-422.
21. Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37: 1595-1607.
22. Hong J, Li G, Li C, Hui R, Sun S, et al. (2002) [Relationship between calpain-10 gene polymorphism, hypertension and plasma glucose]. Zhonghua Nei Ke Za Zhi 41: 370-373.
23. Chen SF, Lu XF, Yan WL, Huang JF, Gu DF (2007) Variations in the calpain-10 gene are associated with the risk of type 2 diabetes and hypertension in northern Han Chinese population. Chin Med J (Engl) 120: 2218-2223.
24. Garant MJ, Kao WH, Brancati F, Coresh J, Rami TM, et al. (2002) SNP43 of CAPN10 and the risk of type 2 Diabetes in African-Americans: the Atherosclerosis Risk in Communities Study. Diabetes 51: 231-237.
25. Shima Y, Nakanishi K, Odawara M, Kobayashi T, Ohta H (2003) Association of the SNP-19 genotype 22 in the calpain-10 gene with elevated body mass index and hemoglobin Alc levels in Japanese. Clin Chim Acta 336: 89-96.
26. Wu B, Takahashi J, Fu M, Cheng H, Matsumura S, et al. (2005) Variants of calpain 10 gene and its association with type 2 diabetes mellitus in a Chinese population. Diabetes Res Clin Pract 68: 155-161.
27. Carlsson E, Fredriksson J, Group L, Ridderstrale M (2004) Variation in the calpain-10 gene is associated with elevated triglyceride levels and reduced adipose tissue messenger ribonucleic acid expression in obese Swedish subjects. J Clin Endocrinol Metab 89: 3601-3605.
28. Kang ES, Nam M, Kim HJ, Kim HJ, Myoung SM, et al. (2006) Haplotype combination of Calpain-10 gene polymorphism is associated with metabolic syndrome in type 2 diabetes. Diabetes Res Clin Pract 73: 268-275.
29. Martinez-Larrad MT, Fernandez-Perez C, Gonzalez-Sanchez JL, Lopez A, Fernandez-Alvarez J, et al. (2005) [Prevalence of the metabolic syndrome (ATP-III criteria). Population-based study of rural and urban areas in the Spanish province of Segovia]. Med Clin (Barc) 125: 481-486.
30. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, et al. (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26: 3160-3167.
31. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
32. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C (2004) Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109: 433-438.
33. Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome - a new worldwide definition. Lancet 366: 1059-1062.
34. Evans JC, Frayling TM, Cassell PG, Saker PJ, Hitman GA, et al. (2001) Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. Am J Hum Genet 69: 544-552.
35. Ronaghi M, Karamohamed S, Pettersson B, Uhlen M, Nyren P (1996) Real-time DNA sequencing using detection of pyrophosphate release. Anal Biochem 242: 84-89.
36. Sasieni PD (1997) From genotypes to genes: doubling the sample size. Biometrics 53: 1253-1261.
37. Tregouet DA, Escolano S, Tiret L, Mallet A, Golmard JL (2004) A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm. Ann Hum Genet 68: 165-177.
38. Weedon MN, Schwarz PE, Horikawa Y, Iwasaki N, Illig T, et al. (2003) Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility. Am J Hum Genet 73: 1208-1212.
39. Brown AL, Yeaman SJ, Walker M (2007) Targeted suppression of calpain-10 expression impairs insulin-stimulated glucose uptake in cultured primary human skeletal muscle cells. Mol Genet Metab 91: 318-324.
40. Xu QS, Xu S, Yun CH, Kwan HL (2006) [Single nucleotide polymorphisms and genotype combinations in calpain-10 gene of Korean population]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 23: 100-102
41. Clark VJ, Cox NJ, Hammond M, Hanis CL, Di Rienzo A (2005) Haplotype structure and phylogenetic shadowing of a hypervariable region in the CAPN10 gene. Hum Genet 117: 258-266.
42. Vander Molen J, Frisse LM, Fullerton SM, Qian Y, Del Bosque-Plata L, et al. (2005) Population genetics of CAPN10 and GPR35: implications for the evolution of type 2 diabetes variants. Am J Hum Genet 76: 548-560.
43. Neel JV (1962) Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet 14: 353-362.
44. Cox NJ, Frigge M, Nicolae DL, Concannon P, Hanis CL, et al. (1999) Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans. Nat Genet 21: 213-215.
45. Poretsky L, Kalin MF (1987) The gonadotropic function of insulin. Endocr Rev 8: 132-141.
46. Jones ME, Thorburn AW, Britt KL, Hewitt KN, Wreford NG, et al. (2000) Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci U S A 97: 12735-12740.